No abstract available
MeSH terms
-
Humans
-
Peritoneal Dialysis, Continuous Ambulatory / adverse effects*
-
Peritoneal Dialysis, Continuous Ambulatory / methods
-
Peritoneal Fibrosis / etiology
-
Peritoneal Fibrosis / prevention & control*
-
Peritoneal Fibrosis / therapy
-
Primary Prevention / methods*
-
Prognosis
-
Renal Dialysis / methods
-
Risk Assessment
-
Severity of Illness Index
-
Tamoxifen / therapeutic use